Every dose you draw at the 2.5mg/mL unit calculations is actually delivering about 67% of the intended dose
Research interest has focused on tendon injuries, ligament injuries, meniscus injuries, general soft tissue recovery, and osteoarthritis-related symptoms
The compound works by targeting a specific methyltransferase enzyme that affects how the body processes molecules critical for cellular function and energy management
While it is not a cure-all, providing the mitochondria with their necessary fuel can help expand a patient's energy envelope, potentially reducing the severity and duration of post-exertional malaise (PEM) crashes
Krivic A, Majerovic M, Jelic I, Seiwerth S, Sikiric P
MOTS-c is a research compound sold for laboratory and research use only